| 1 |
32112562 | The Magnitude of the Warfarin-Amiodarone Drug-Drug Interaction Varies With Renal Function: A Propensity-Matched Cohort Study. | 2020 Jun |
1 |
| 2 |
30689138 | Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? | 2019 Mar |
3 |
| 3 |
28118749 | Warfarin Interaction With Hepatic Cytochrome P-450 Enzyme-Inducing Anticonvulsants. | 2018 Jan |
5 |
| 4 |
28686070 | Effects of aging and rifampicin pretreatment on the pharmacokinetics of human cytochrome P450 probes caffeine, warfarin, omeprazole, metoprolol and midazolam in common marmosets genotyped for cytochrome P450 2C19. | 2018 Jul |
1 |
| 5 |
29858511 | Cytochrome P450 genotype-guided drug therapies: An update on current states. | 2018 Oct |
2 |
| 6 |
26161443 | A chiral HPLC-MS/MS method for simultaneous quantification of warfarin enantiomers and its major hydroxylation metabolites of CYP2C9 and CYP3A4 in human plasma. | 2014 |
2 |
| 7 |
22317799 | Warfarin genotyping in a single PCR reaction for microchip electrophoresis. | 2012 Apr |
1 |
| 8 |
18838506 | Mechanism-based inactivation of cytochrome P450 2C9 by tienilic acid and (+/-)-suprofen: a comparison of kinetics and probe substrate selection. | 2009 Jan |
1 |
| 9 |
20002088 | Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A. | 2009 Dec |
1 |
| 10 |
17708140 | The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. | 2007 Aug 1 |
1 |
| 11 |
19356015 | Prioritization of clinical drug interaction studies using in vitro cytochrome P450 data: proposed refinement and expansion of the "rank order" approach. | 2007 Jan |
1 |
| 12 |
16639745 | Multiple molecular dynamics simulations of human p450 monooxygenase CYP2C9: the molecular basis of substrate binding and regioselectivity toward warfarin. | 2006 Jul 1 |
4 |
| 13 |
15767245 | Enhanced antithrombotic effect of warfarin associated with low-dose alcohol consumption. | 2005 Feb |
4 |
| 14 |
16162970 | In-vitro cytotoxicity of ET-743 (Trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction. | 2005 Oct |
1 |
| 15 |
15197521 | Increased liability of tramadol-warfarin interaction in individuals with mutations in the cytochrome P450 2D6 gene. | 2004 Jul |
1 |
| 16 |
12728288 | Determination of bleeding risk using genetic markers in patients taking phenprocoumon. | 2003 Jul |
2 |
| 17 |
12814453 | Evidence of an interaction between nifedipine and nafcillin in humans. | 2003 Jun |
2 |
| 18 |
11893129 | The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin. | 2002 Mar |
5 |
| 19 |
11343389 | Extreme warfarin sensitivity in siblings associated with multiple cytochrome P450 polymorphisms. | 2001 Jun |
4 |
| 20 |
11523725 | Pharmacogenetics of warfarin elimination and its clinical implications. | 2001 |
2 |
| 21 |
10923005 | Cytochrome P450 polymorphisms are associated with reduced warfarin dose. | 2000 Aug |
4 |
| 22 |
9068934 | Effect of sertraline on protein binding of warfarin. | 1997 |
2 |
| 23 |
8801056 | Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies. | 1996 Apr |
2 |
| 24 |
8801058 | Warfarin-fluconazole. III. A rational approach to management of a metabolically based drug interaction. | 1996 Apr |
1 |
| 25 |
1581537 | Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. | 1992 Jan-Feb |
3 |
| 26 |
3276317 | Warfarin: metabolism and mode of action. | 1988 Jan 1 |
2 |
| 27 |
2895455 | Clinically important adverse effects and drug interactions with H2-receptor antagonists: an update. | 1987 |
1 |
| 28 |
3333881 | Aspects of anticoagulant action: a review of the pharmacology, metabolism and toxicology of warfarin and congeners. | 1987 |
1 |
| 29 |
6096071 | Interactions and non-interactions with ranitidine. | 1984 Nov-Dec |
1 |
| 30 |
6148215 | Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin. | 1984 Jul-Aug |
4 |
| 31 |
6747992 | The preferred solution conformation of warfarin at the active site of cytochrome P-450 based on the CD spectra in octanol/water model system. | 1984 Aug |
5 |
| 32 |
6860533 | Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpyrazone interaction. | 1983 May |
2 |
| 33 |
31893 | Cumene hydroperoxide-supported microsomal hydroxylations of warfarin--a probe of cytochrome P-450 multiplicity and specificity. | 1979 |
1 |